Cardiac Assist Devices Market Size, Share, Trends, Growth Outlook

Cardiac Assist Devices Market is estimated to increase at a Compounded Annual Growth Rate of 7.8% CAGR over the forecast period from 2024 to 2030

The Cardiac Assist Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Intra-aortic Balloon Pump, Total Artificial Heart, Ventricular Assist Device), By Modality (Transcutaneous, Implantable), By End-User (Hospital Pharmacies, Ambulatory Surgical Centers).

An Introduction to Cardiac Assist Devices Market in 2024

In 2024, the market for cardiac assist devices addresses the therapeutic needs of patients with advanced heart failure, offering mechanical circulatory support systems, ventricular assist devices (VADs), and temporary cardiac support devices for improving hemodynamic stability, end-organ perfusion, and quality of life while awaiting heart transplantation or as destination therapy for ineligible transplant candidates. Cardiac assist devices function by supplementing or replacing the pumping action of the failing heart, providing mechanical support to the left ventricle, right ventricle, or both chambers of the heart to maintain adequate cardiac output and systemic perfusion. With a focus on patient survival, functional recovery, and adverse event mitigation, cardiac assist devices offer various implantation options, including intracorporeal and extracorporeal systems, tailored to patient anatomy, hemodynamic profile, and clinical status. Moreover, with advancements in device miniaturization, implantation techniques, and remote monitoring capabilities, the cardiac assist devices market continues to evolve, offering improved durability, enhanced patient mobility, and integrated care management solutions for optimizing patient outcomes and quality of life in advanced heart failure management.

Market Trend: Miniaturization and Advancements in Device Technology

A significant trend in the Cardiac Assist Devices market is the miniaturization and advancements in device technology. Cardiac assist devices, including ventricular assist devices (VADs) and intra-aortic balloon pumps (IABPs), are undergoing continuous innovation to become smaller, more durable, and more sophisticated. Miniaturization allows for less invasive implantation procedures and improves patient comfort and mobility. Furthermore, advancements in device technology, such as the incorporation of wireless connectivity, remote monitoring capabilities, and advanced algorithms for hemodynamic management, enhance device performance and patient outcomes. As technology evolves, there's a growing demand for next-generation cardiac assist devices that offer improved functionality, reliability, and patient satisfaction.

Market Driver: Increasing Prevalence of Heart Failure and Advanced Cardiac Diseases

An important driver fueling the Cardiac Assist Devices market is the increasing prevalence of heart failure and advanced cardiac diseases. Heart failure is a chronic and progressive condition affecting millions of people worldwide, with a significant proportion of patients progressing to end-stage heart failure necessitating advanced cardiac support. Cardiac assist devices play a crucial role in managing advanced heart failure by providing mechanical circulatory support and improving cardiac function, quality of life, and survival outcomes. As the global burden of heart failure continues to rise due to factors such as aging populations, sedentary lifestyles, and the growing incidence of cardiovascular risk factors, there's a parallel increase in the demand for cardiac assist devices as essential therapeutic options for patients with advanced cardiac diseases.

Market Opportunity: Expansion into Destination Therapy and Ambulatory Care Settings

A significant opportunity within the Cardiac Assist Devices market lies in the expansion into destination therapy and ambulatory care settings. While cardiac assist devices have traditionally been used as a bridge to transplant or as temporary support during acute exacerbations of heart failure, there's a growing trend towards their utilization as destination therapy for patients ineligible for heart transplantation. Additionally, advancements in device technology and surgical techniques have enabled the transition of selected patients to ambulatory care settings, allowing for outpatient management of chronic heart failure with long-term mechanical circulatory support. By expanding the indications for use and exploring new care delivery models, manufacturers and healthcare providers can capitalize on this market opportunity and address the evolving needs of patients with advanced cardiac diseases, ultimately improving access to life-saving cardiac assist therapies.

Cardiac Assist Devices Market Share Analysis: Ventricular Assist Devices (VADs)

Among the various products in the cardiac assist devices market, ventricular assist devices (VADs) are experiencing significant growth. VADs are implantable mechanical pumps designed to assist or replace the function of a failing heart's ventricles. The rapid growth of VADs can be attributed to several factors. Firstly, the increasing prevalence of heart failure worldwide, coupled with the shortage of donor hearts for transplantation, has led to a growing demand for mechanical circulatory support devices such as VADs. Secondly, advancements in VAD technology, including miniaturization, improved durability, and enhanced hemocompatibility, have improved device reliability and patient outcomes, driving increased adoption by healthcare providers. Additionally, the expanding indications for VAD therapy, including destination therapy for patients ineligible for heart transplantation, are broadening the patient population eligible for VAD implantation. Moreover, the growing trend towards outpatient implantation and management of VAD patients in ambulatory surgical centers is facilitating greater access to VAD therapy for eligible patients. As a result, the VADs segment is expected to continue experiencing cardiac assist devices market, presenting significant opportunities for manufacturers, healthcare providers, and other stakeholders involved in the management of heart failure patients.

Cardiac Assist Devices Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, Abiomed Inc, Berlin Heart GmbH, BiVACOR Inc, Getinge AB, Jarvik Heart Inc, Medtronic PLC, SynCardia Systems Inc, Teleflex Inc

Cardiac Assist Devices Market Segmentation

By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Cardiac Assist Devices Market Companies

Abbott Laboratories
Abiomed Inc
Berlin Heart GmbH
BiVACOR Inc
Getinge AB
Jarvik Heart Inc
Medtronic PLC
SynCardia Systems Inc
Teleflex Inc

Reasons to Buy the Cardiac Assist Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cardiac Assist Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cardiac Assist Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Cardiac Assist Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Cardiac Assist Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Cardiac Assist Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cardiac Assist Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cardiac Assist Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cardiac Assist Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Cardiac Assist Devices Industry
4.2 Key Market Trends in Cardiac Assist Devices Industry
4.3 Potential Opportunities in Cardiac Assist Devices Industry
4.4 Key Challenges in Cardiac Assist Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Cardiac Assist Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Cardiac Assist Devices Market Outlook by Segments
7.1 Cardiac Assist Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers

8 North America Cardiac Assist Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Cardiac Assist Devices Markets in 2024
8.2 North America Cardiac Assist Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cardiac Assist Devices Market size Outlook by Segments, 2021-2030
By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers

9 Europe Cardiac Assist Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Cardiac Assist Devices Markets in 2024
9.2 Europe Cardiac Assist Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cardiac Assist Devices Market Size Outlook by Segments, 2021-2030
By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers

10 Asia Pacific Cardiac Assist Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Cardiac Assist Devices Markets in 2024
10.2 Asia Pacific Cardiac Assist Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cardiac Assist Devices Market size Outlook by Segments, 2021-2030
By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers

11 South America Cardiac Assist Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Cardiac Assist Devices Markets in 2024
11.2 South America Cardiac Assist Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cardiac Assist Devices Market size Outlook by Segments, 2021-2030
By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers
12 Middle East and Africa Cardiac Assist Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Cardiac Assist Devices Markets in 2024
12.2 Middle East and Africa Cardiac Assist Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cardiac Assist Devices Market size Outlook by Segments, 2021-2030
By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Abiomed Inc
Berlin Heart GmbH
BiVACOR Inc
Getinge AB
Jarvik Heart Inc
Medtronic PLC
SynCardia Systems Inc
Teleflex Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Intra-aortic Balloon Pump
Total Artificial Heart
Ventricular Assist Device
-Left Ventricular Assist Device
-Right Ventricular Assist Device
By Modality
Transcutaneous
Implantable
By End-User
Hospital Pharmacies
Ambulatory Surgical Centers
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)